Latest Breaking News On - Beckley foundation - Page 3 : comparemela.com

Psyched: Defense Dept s Ketamine Trial, Cybin s Psilocybin, Metabolic Disorders, Reform Update And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

Defense Dept. Funds Ketamine Study For PTSD Treatment 

Enveric biosciencesIncannex healthcareClearmind medicineSeelos therapeuticsCybin incA psychedelic therapy programSignature program for personal discoveryAmanda feilding beckley foundationScisparc ltdClearmind medicine incHealth agency fundedNovel psilocybin topline dataMajor depressive disorderPsychedelic based treatmentRetreats kicks offNew program

Beckley Retreats Launches Signature Program for Personal Discovery and Transformation

Beckley Retreats Launches Signature Program for Personal Discovery and Transformation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Terence mckennaAmanda feildingNeil markeyAlbert hofmannNeil daviesAlexandra pallasAnn shulginSignature program for personal discoveryBeckley foundationBeckley retreat signature programBroadsheet communications for beckley retreatsWill introduceSignature programPersonal discoveryRetreat signature programBeckley waves

Of minds and choices | The Isis

Of minds and choices | The Isis
isismagazine.org.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from isismagazine.org.uk Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofJose maria cuellarDavid cameronStephen reidRobin carhartt harrisEthan nadelmannPsychedelic societyPsychedelic society of londonComplexity sciences at bristolImperial collegeEconomic foundationBeckley foundationDrug policy allianceProfessor david nuttComplexity sciences

First Patient Dosed in Beckley Psytech s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD) | Region

OXFORD, England (BUSINESS WIRE) Oct 24, 2023

United kingdomUnited statesCosmo feilding mellenBeckley psytechRob conleyCharlotte chorleyBeckley foundationUnited statesfoodand drug administrationBeckley psytech ltdPsytech ltdTreatment resistant depressionInvestigational new drugMontgomery asberg depression rating scaleChief scientific officerBusiness wire

Beckley Psytech Ltd: First Patient Dosed in Beckley Psytech s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD)

Beckley Psytech Ltd: First Patient Dosed in Beckley Psytech s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomIndiens wirtschaftBeckley psytechRob conleyCharlotte chorleyCosmo feilding mellenIhre chancenBeckley foundationDrug administrationBeckley psytech ltdTreatment resistant depressionPsytech ltdInvestigational new drugMontgomery asberg depression rating scaleChief scientific officer